Recommendations for the definition of clinical responder in insulin preservation studies
about
Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.Strategies for clinical trials in type 1 diabetesAntigen-based immunotherapies do not prevent progression of recent-onset autoimmune diabetes: a systematic review and meta-analysis.Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
P2860
Recommendations for the definition of clinical responder in insulin preservation studies
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recommendations for the definition of clinical responder in insulin preservation studies
@ast
Recommendations for the definition of clinical responder in insulin preservation studies
@en
Recommendations for the definition of clinical responder in insulin preservation studies
@nl
type
label
Recommendations for the definition of clinical responder in insulin preservation studies
@ast
Recommendations for the definition of clinical responder in insulin preservation studies
@en
Recommendations for the definition of clinical responder in insulin preservation studies
@nl
prefLabel
Recommendations for the definition of clinical responder in insulin preservation studies
@ast
Recommendations for the definition of clinical responder in insulin preservation studies
@en
Recommendations for the definition of clinical responder in insulin preservation studies
@nl
P2093
P2860
P356
P1433
P1476
Recommendations for the definition of clinical responder in insulin preservation studies
@en
P2093
Craig A Beam
Jerry P Palmer
Stephen E Gitelman
Type 1 Diabetes TrialNet Study Group
P2860
P304
P356
10.2337/DB14-0095
P407
P577
2014-04-10T00:00:00Z